Talcum Powder Cancer Lawsuit

Goodbye to 2020 and Hello to New Johnson & Johnson Baby Powder Cancer Trials and Revelations

2021 should bring new Johnson's Baby Powder cancer trials once Covid-19 is behind us

Thursday, December 24, 2020 - The new year offers promise to individuals that have used Johnson's Baby Powder regularly for many years for feminine hygiene and have developed ovarian cancer. Others that used Johnson's Baby Powder as a drying agent in between showers allege that doing so caused them to inhale the talc dust and with it deadly asbestos fibers that have caused mesothelioma, a scarring of the lining of the lungs and stomach. There has been a lull in the action in 2020 due primarily to court delays from the lockdowns and other restrictions placed on the public over fears generated by the Corona Virus. The most notable developments in 2020 were a New York State judged upholding a verdict against Johnson & Johnson that was being appealed and reducing the jury award from $325 million to 120 million dollars, an amount in line with actual damages. The plaintiff testified she had used either Johnson's Baby Powder or Shower to Shower regularly for the last 50 years and is now suffering from the late stages of mesothelioma. The judge in the case chastised Johnson & Johnson for willfully ignoring what the company knew or were expected to know about the safety of their product used by millions around the world. According to Reuters, "Judge Lebovits wrote that jurors could find that Johnson & Johnson was for many years "knowingly deceitful about" or "willfully blind to" potential health risks of its talc products, in part to maintain market share and profit." Talcum powder cancer lawsuit attorneys provide legal representation for baby powder lawsuits on a contingency basis, meaning we charge no legal fees unless we win compensation on your behalf.

The appellate judge's findings and the opinion of Federal Judge Freda Wolfson who presided over a week of Johnson's Baby Powder Daubert Hearings in July of 2019, in which the judge determined expert witnesses that have found asbestos in talc could present their findings to future juries, may have influenced Johnson & Johnson's decision to voluntarily discontinue selling Johnson's Baby Powder in all of North America. Legal experts think those events could have contributed to the company deciding to settle out of court with 1000 women suffering from ovarian cancer for the sum of $100 million.

Another significant development in 2020 was Imery Inc., the sole talc supplier for Johnson & Johnson and hundreds of other women's beauty and cosmetic companies, completing the sale of their North American talc mining operations, and placing the proceeds in escrow to pay future talc asbestos cancer claims. Imerys had been named as a co-defendant in numerous talcum powder asbestos cancer trials and their North American subsidiary had been placed in bankruptcy until it could be sold. It has since come to light that many cosmetics companies like Revlon, Clubman, and Colgate Palmolive may have never actually tested their products for the presence of asbestos, relying instead on Imery's representation of guaranteeing the purity of the talc they sold. Unfortunately for consumers, Imerey considered talc that contained a small amount of asbestos pure, in spite of the Food and Drug Administration declaring that there is no safe amount of asbestos and even the smallest inhaled or ingested asbestos fiber could eventually cause cancer.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.